Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.87 AUD | -1.56% | -2.93% | +18.23% |
Mar. 14 | Bell Potters Starts Mcmillan Shakespeare at Buy With AU$22.52 Price Target | MT |
Mar. 13 | McMillan Shakespeare Limited Announces Resignation of Ashley Conn as Company Secretary | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- The company is one of the best yield companies with high dividend expectations.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company is in debt and has limited leeway for investment
- The company's enterprise value to sales, at 3.13 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Consumer Lending
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+18.23% | 868M | C+ | ||
-6.94% | 54.11B | C+ | ||
-4.00% | 31.94B | C+ | ||
+64.11% | 29.16B | - | - | |
+20.29% | 23.61B | B | ||
+16.94% | 18.17B | B | ||
-7.70% | 11.64B | C+ | ||
+23.43% | 11.25B | B- | ||
-23.72% | 8.02B | - | ||
+15.13% | 7.98B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MMS Stock
- Ratings McMillan Shakespeare Limited